Regulus Therapeutics to Present at the 2020 Wells Fargo Virtual Healthcare Conference - Link to sli | RGLS Message Board Posts

Regulus Therapeutics Inc.

  RGLS website
  • Here We Go Again: Apparently, it's just one of those years. We here in the Greater New Orleans Area now find ourselves "in the cone" for the 7th time this year. And while we more or less dodged bullets the first 6 times, it looks like this time Zeta is going to hit close enough to do damage. We can only hope it stays a relatively minor Cat 1 & weakens upon approach. But preparations are once again in order for those of us living along the central Gulf Coast. Members with family or other interests in the affected area are welcome to post on the new Hurricane Zeta Self-Help board we just set up. Good luck & stay safe! 

RGLS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  622 of 629  at  9/14/2020 6:37:52 PM  by

Steve_382

The following message was updated on 9/14/2020 6:40:24 PM.

 In response to msg 621 by  arthurs1
view thread

Re: Regulus Therapeutics to Present at the 2020 Wells Fargo Virtual Healthcare Conference - Link to slides

  
 From one of the slides it sounds like not too soon. I will try to listen to the HC Wainwright CC tomorrow and see if they give any additional clues.
 It's at 11 AM.
 
 
 
 
RG-012, Anti-miR-21 for the Treatment of Alport SyndromePhase 2 Currently Enrolling Patients
Chronic treatment with RG-012 is well tolerated (Q2W for one year)
Clinical demonstration of desired exposure and modulation of microRNA target in kidney
Sanofi has assumed development responsibility; initiation and recruitment for Phase 2 study underway. Regulus believes new site initiation and patient enrollment has been impacted by COVID-19 pandemic
Partnership recently restructured providing for $5m in revised milestones upon receipt of RG-012 materials and remaining $5m upon achievement of interim enrollment milestone. Regulus eligible to receive additional $25M development milestone.
 
 
They also had this on another slide:
 
Achievement of Sanofi milestone payments to pay down venture debt with potential for additional seven months of interest-only payments through 2021 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 49
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






Financial Market Data provided by
.
Loading...